Increased CCL2 expression and macrophage/monocyte migration during microbicide-induced vaginal irritation

Current HIV Research

Volumn 7, Issue 6, 2009, Pages 639-649

  Alt, Carsten ^a   Harrison, Travis ^a   Dousman, Linda ^a   Fujita, Nahoko ^a   Shew, Ken ^a   Tran, Thanh Thuy ^a   Shayesteh, Sara ^a   Matsukawa, Akihiro ^b   Mirsalis, Jon ^a   D'Andrea, Annalisa ^a  

^a SRI INTERNATIONAL   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

AIDS; Biomarker; Chemokine; Cytokine; HIV; Sexually transmitted disease

Indexed keywords

ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NONOXINOL 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; LEUKOCYTE MIGRATION; MACROPHAGE; MONOCYTE; NONHUMAN; RABBIT; VAGINITIS;

ANIMALS; BENZALKONIUM COMPOUNDS; BIOLOGICAL MARKERS; CELL MOVEMENT; CHEMOKINE CCL2; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; MACROPHAGES; MONOCYTES; NONOXYNOL; RABBITS; SURFACE-ACTIVE AGENTS; VAGINA;

EID: 73949140784     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209789973682     Document Type: Article

References (41)

1. UNAIDS/WHO. AIDS epidemic update. Geneva, CH: UN/WHO; 2006; p. 1-96.
2. August 2008 Pipeline Update. Silver Spring, MD, USA,: Alliance for Microbicide Development; [August 04, 2008; cited]; August 04, 2008, http://www.microbicide.org]. Available from: http://www.microbicide.org.
3. Lederman MM, Offord RE, Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 2006; 6: 371-82.
4. Ramjee G, Doncel GF, Mehendale S, Tolley EE, Dickson K. Microbicides 2008 Conference: From Discovery to Advocacy. AIDS Res Ther 2008; 5: 19.
5. Check E. Scientists rethink approach to HIV gels. Nature 2007; 446: 12.
6. Honey K. Microbicide trial screeches to a halt. J Clin Invest 2007; 117: 1116.
7. Cohen J. AIDS research. Microbicide fails to protect against HIV. Science 2008; 319: 1026-7.
8. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268: 477-82.
9. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339: 504-10.
10. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-7.
11. Zekeng L, Feldblum PJ, Oliver RM, Kaptue L. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 1993; 7: 725-31.
12. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233: 1089-93.
13. Silverstein G. Anti-HIV microbicides: don't forget basic immunology. Lancet 2007; 369: 1429.
14. Eckstein P, Jackson MC, Millman N, Sobrero AJ. Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. J Reprod Fertil 1969; 20: 85-93.
15. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, Shattock RJ. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74: 5577-86.
16. Fichorova RN, Bajpai M, Chandra N, et al. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod 2004; 71: 761-9.
17. Schroder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139: 3474-83.
18. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485-90.
19. Matsukawa A, Miyazaki S, Maeda T, et al. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8. Lab Invest 1998; 78: 973-85.
20. Matsukawa A, Yoshimura T, Fujiwara K, Maeda T, Ohkawara S, Yoshinaga M. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFalpha, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein. Lab Invest 1999; 79: 591-600.
21. Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystalinduced rabbit arthritis. Lab Invest 1998; 78: 559-69.
22. Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Lab Invest 1997; 76: 629-38.
23. Doncel GF, Chandra N, Fichorova RN. Preclinical assessment of the proinflammatory potential of microbicide candidates. J Acquir Immune Defic Syndr 2004; 37(Suppl 3): S174-80.
24. Grillner L, Landqvist M. Enzyme-linked immunosorbent assay for detection and typing of herpes simplex virus. Eur J Clin Microbiol 1983; 2: 39-42.
25. Boyle W. An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation 1968; 6: 761-4.
26. Gendelman HE, Orenstein JM, Baca LM, et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989; 3: 475-95.
27. Roy S, Wainberg MA. Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS). J Leukoc Biol 1988; 43: 91-7.
28. Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008; 77: 32-40.
29. Narimatsu R, Wolday D, Patterson BK. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 2005; 21: 228-33.
30. Miller CJ, Alexander NJ, Gettie A, Hendrickx AG, Marx PA. The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertil Steril 1992; 57: 1126-8.
31. Weber J, Nunn A, O'Connor T, et al. 'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS 2001; 15: 1563-8.
32. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118: 503-8.
33. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005; 201: 1355-9.
34. Koch AE, Kunkel SL, Burrows JC, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991; 147: 2187-95.
35. Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998; 9: 9-23.
36. Forslund O, Lindelof B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol 2004; 123: 388-94.
37. Soboll G, Schaefer TM, Wira CR. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. Am J Reprod Immunol 2006; 55: 434-46.
38. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994; 91: 3652-6.
39. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11: 97-101.
40. Milligan GN, Dudley KL, Bourne N, Reece A, Stanberry LR. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis 2002; 29: 597-605.
41. Milligan GN, Young CG, Meador MG, Chu CF, Stanberry LR. Effects of candidate vaginally-applied microbicide compounds on innate immune cells. J Reprod Immunol 2005; 66: 103-16.